98%
921
2 minutes
20
DNAzymes - synthetic enzymes made of DNA - have long attracted attention as RNA-targeting therapeutic agents. Yet, as of now, no DNAzyme-based drug has been approved, partially due to our lacking understanding of their molecular mode of action. In this work we report the solution structure of 8-17 DNAzyme bound to a Zn ion solved through NMR spectroscopy. Surprisingly, it turned out to be very similar to the previously solved Pb-bound form (catalytic domain RMSD = 1.28 Å), despite a long-standing literature consensus that Pb recruits a different DNAzyme fold than other metal ion cofactors. Our follow-up NMR investigations in the presence of other ions - Mg, Na, and Pb - suggest that at DNAzyme concentrations used in NMR all these ions induce a similar tertiary fold. Based on these findings, we propose a model for 8-17 DNAzyme interactions with metal ions postulating the existence of only a single catalytically-active structure, yet populated to a different extent depending on the metal ion cofactor. Our results provide structural information on the 8-17 DNAzyme in presence of non-Pb cofactors, including the biologically relevant Mg ion.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11101458 | PMC |
http://dx.doi.org/10.1038/s41467-024-48638-x | DOI Listing |
Biosens Bioelectron
November 2025
International Centre for Quantum and Molecular Structures and the School of Physics, Shanghai University, 200444, Shanghai, China; School of Mathematical and Physical Sciences, University of Technology Sydney, Sydney, NSW, 2007, Australia. Electronic address:
DNAzymes are metal-dependent catalysts with vast potential for therapeutic and diagnostic applications. Herein, optimization of the performance of a commercial laboratory fluorescence resonance energy transfer (FRET) biosensor, that is currently used to detect, with 1 fM sensitivity, the ompA gene of Chlamydia trachomatis, is considered through the addition of 20-40 μM of Cd to model biosensors. Up to 10-fold signal enhancement is observed in pertinent solution-based sensing formats based on 8-17 DNAzyme, the mechanism of which is determined using molecular-mechanics simulations of the operation of its catalytic site.
View Article and Find Full Text PDFBioorg Med Chem Lett
December 2025
School of Pharmaceutical Sciences, Guizhou University, Guiyang 550025, China. Electronic address:
MNAzymes were derived from catalytic DNAzymes (10-23, 8-17, 17E, et al) with a split catalytic core at certain positions, an extra oligonucleotide (termed as initiating oligonucleotide) was introduced to recover the catalytic core and the catalytic activity. With this initiating oligonucleotide, thus, the applications of MNAzymes as the detection biosensors have been expanded dramatically to a wide range of analytes of interest. However, the split catalytic core of MNAzymes is less active than the intact DNAzymes, many designs were concentrated on the signaling methods for a better performance.
View Article and Find Full Text PDFACS Sens
June 2025
School of Pharmaceutical Sciences, Guizhou University, Guiyang 550025, China.
8-17 DNAzyme is a well-known versatile nucleic acid tool for achieving a specific cleavage function, and thus, investigation of 8-17 DNAzyme functions can prove to be of great significance. The conventional epigenetic modification on DNAzyme may pave a new way for the study of catalytic properties. Herein, the most abundant and best characterized modifications 5-methylcytosine (5mC) and -methyladenosine (m6A) are introduced into the central catalytic core and stem sequence of 8-17 DNAzyme to evaluate the cleavage activity.
View Article and Find Full Text PDFAnal Chem
May 2025
College of Chemistry and Chemical Engineering, Precise Synthesis and Function Development Key Laboratory of Sichuan Province, Institute of Applied Chemistry, China West Normal University, Nanchong, Sichuan637000, China.
DNAzyme-based biosensors remain at the forefront of microRNA (miRNA) analysis efforts. In this work, an electrochemiluminescence (ECL) biosensor technology integrating miRNA-initiated DNAzyme with a near-infrared ECL emission system was designed to detect miRNA. The DNAzyme was designed through the rational reconstitution of Mg-specific 8-17 DNAzyme.
View Article and Find Full Text PDFOrg Biomol Chem
May 2025
Chemical Sciences Department, Universidad Andres Bello, Santiago, Chile.
RNA-cleaving DNAzymes have emerged as promising catalytic nucleic acids with potential applications in biotechnology and therapeutics. Among them, the 10-23 and 8-17 DNAzymes, both derived from the same selection experiment, have emerged as the most widely studied RNA-cleaving DNAzymes due to their high catalytic efficiency and broad metal ion dependence. Despite their apparent structural differences, recent structural, functional, and computational studies have revealed convergent catalytic strategies in their mechanisms.
View Article and Find Full Text PDF